0
0
1/24/23 at 4:28pm
Organization
News-Medical.Net
45 words
0
Comments
Researchers determined the association between adverse events of special interest (AESIs) following BNT162b2 vaccination, a coronavirus disease 2019 (COVID-19) vaccine based on the messenger ribonucleic acid (mRNA) technology.
You are the first to view
https://www.news-medical.net/news/20230124/New-study-evaluates-the-safety-profile-of-the-BNT162b2-vaccine-in-New-Zealand.aspx
Create an account
or login to join the discussion